{"id":31,"date":"2008-07-09T13:40:19","date_gmt":"2008-07-09T21:40:19","guid":{"rendered":"http:\/\/blogs.edf.org\/nanotechnology\/2008\/07\/09\/parlez-vous-nano-edf-and-dupont-translate-nano-risk-framework\/"},"modified":"2024-02-12T11:01:30","modified_gmt":"2024-02-12T16:01:30","slug":"parlez-vous-nano-edf-and-dupont-translate-nano-risk-framework","status":"publish","type":"post","link":"https:\/\/blogs.edf.org\/health\/2008\/07\/09\/parlez-vous-nano-edf-and-dupont-translate-nano-risk-framework\/","title":{"rendered":"Parlez-vous Nano? EDF and DuPont translate Nano Risk Framework"},"content":{"rendered":"<p><em>\u00a0<span style=\"color: #003874;\"><em>Scott Walsh, MBA<\/em><\/span>, is a Project Manager.<\/em><\/p>\n<p>Nanotechnology is a global phenomenon:\u00a0 Organizations all over the world are working to develop and deploy nanotechnology applications.\u00a0 Interest in minimizing the potential health, environmental and safety risks of nanotechnology is similarly global.\u00a0 One of many indications:\u00a0 Over the past year, EDF and DuPont&#8217;s <a href=\"http:\/\/http:\/\/www.nanoriskframework.com\/\">Nano Risk Framework\u00a0<\/a> has been downloaded more than 3,000 times in nearly 100 countries.<\/p>\n<p>Recognizing the international interest in the Framework, EDF and DuPont have now made it available in three major languages: <a href=\"http:\/\/www.nanoriskframework.com\/mandarin\">Mandarin<\/a>, <a href=\"http:\/\/http:\/\/www.nanoriskframework.com\/french\">French<\/a>, and <a href=\"http:\/\/http:\/\/www.nanoriskframework.com\/spanish\">Spanish<\/a>. (The Framework&#8217;s executive summary is also available in Portuguese.) These translations will allow organizations around the world to better understand and apply the Framework&#8217;s guidance to assess, mitigate, and communicate about potential nanomaterial risks.<\/p>\n<p><!--more--><\/p>\n<p>EDF and DuPont launched a partnership in September 2005 to develop a systematic and disciplined process for evaluating and addressing the environmental, health and safety risks of nanomaterials across all stages of a product\u2019s lifecycle \u2013 from initial sourcing through manufacture, use and recycling or disposal.\u00a0 One of the goals of our partnership was to provide input into the ongoing development of policies and practices to address potential nano risks.<\/p>\n<p>A few examples show that our work has had a broad reach:\u00a0 The Organization for Economic Cooperation and Development\u2019s (OECD) <a href=\"http:\/\/http:\/\/www.oecd.org\/department\/0,3355,en_2649_37015404_1_1_1_1_1,00.html\">Working Party on Manufactured Nanomaterials<\/a>, for example, has said it has benefited from the Framework as practical input into its nanotechnology programs.\u00a0 Lloyd&#8217;s, the UK&#8217;s famous insurance syndicate, has <a href=\"http:\/\/www.lloyds.com\/NR\/rdonlyres\/B9C7371E-83D4-49DD-8268-5D6C800FBDDF\/0\/ER_Nanotechnology_Report.pdf\">encouraged insurers<\/a> &#8220;to seek evidence of whether projects they are covering have followed this Framework.&#8221; Here in the U.S., the Framework has been praised by companies ranging from large multinationals like GE to small startups like Nanostellar.<\/p>\n<p>In developing the Framework, we collected feedback from nanotechnology stakeholders around the world.\u00a0 In translating the Framework, we hope to return the favor by making this guidance more accessible to more people across the globe, whether they live in Brasilia or Beijing, Madrid or Marseilles.\u00a0 When it comes to nanotechnology safety, in more ways than one, it&#8217;s a small world after all.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0Scott Walsh, MBA, is a Project Manager. Nanotechnology is a global phenomenon:\u00a0 Organizations all over the world are working to develop and deploy nanotechnology applications.\u00a0 Interest in minimizing the potential health, environmental and safety risks of nanotechnology is similarly global.\u00a0 One of many indications:\u00a0 Over the past year, EDF and DuPont&#8217;s Nano Risk Framework\u00a0 has &#8230;<\/p>\n","protected":false},"author":102,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[44,56087],"tags":[39201],"coauthors":[],"class_list":["post-31","post","type-post","status-publish","format-standard","hentry","category-policy","category-nanotechnology","tag-dupont"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/31","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/users\/102"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/comments?post=31"}],"version-history":[{"count":1,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/31\/revisions"}],"predecessor-version":[{"id":12688,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/posts\/31\/revisions\/12688"}],"wp:attachment":[{"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/media?parent=31"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/categories?post=31"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/tags?post=31"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.edf.org\/health\/wp-json\/wp\/v2\/coauthors?post=31"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}